Increase Speed to Market

Increase Speed to Market

At Biopta we know that time saved equals money saved! Our efficacy models enable you to progress through the drug development process faster than your key competitors. Ex vivo human efficacy data gives you confidence that your compound will perform in the clinical setting and enables you to expedite the decision making process.

We have regular and frequent access to both healthy and diseased tissues allowing us to carry out comparison studies in different patient populations. The data we provide will enable you to streamline your ‘proof of concept’ studies saving both time and money.

Alternatively, save valuable time and money by repositioning your current compounds. Test them for efficacy in alternative indications using one or more of our human tissue assays. Our models are far more cost effective than setting up a clinical efficacy study which has no guarantee of success and in most cases our data can be available within weeks of study initiation.

For more information on how Biopta’s models can be used to determine the efficacy of your compound in humans please click here.

For information on how Biopta can help you prove your compound is safer than the competition please click here.

Live chat by BoldChat